ZA200107425B - Method for the treatment of incontinence. - Google Patents

Method for the treatment of incontinence.

Info

Publication number
ZA200107425B
ZA200107425B ZA200107425A ZA200107425A ZA200107425B ZA 200107425 B ZA200107425 B ZA 200107425B ZA 200107425 A ZA200107425 A ZA 200107425A ZA 200107425 A ZA200107425 A ZA 200107425A ZA 200107425 B ZA200107425 B ZA 200107425B
Authority
ZA
South Africa
Prior art keywords
incontinence
treatment
gamma
instant invention
aminobutyric acid
Prior art date
Application number
ZA200107425A
Other languages
English (en)
Inventor
Catherine A Segal
Leslie Magnus
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22434891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200107425(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA200107425B publication Critical patent/ZA200107425B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
ZA200107425A 1999-04-08 2001-09-07 Method for the treatment of incontinence. ZA200107425B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12834799P 1999-04-08 1999-04-08

Publications (1)

Publication Number Publication Date
ZA200107425B true ZA200107425B (en) 2003-02-26

Family

ID=22434891

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200107425A ZA200107425B (en) 1999-04-08 2001-09-07 Method for the treatment of incontinence.

Country Status (13)

Country Link
EP (2) EP1171114B1 (hu)
JP (1) JP2002541198A (hu)
KR (1) KR20010103053A (hu)
AT (2) ATE463242T1 (hu)
AU (2) AU779262B2 (hu)
CA (1) CA2362026A1 (hu)
DE (2) DE60044160D1 (hu)
ES (2) ES2341059T3 (hu)
HU (1) HUP0200738A3 (hu)
IL (1) IL145763A0 (hu)
TR (1) TR200102837T2 (hu)
WO (1) WO2000061135A1 (hu)
ZA (1) ZA200107425B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003088335A (ja) * 2001-09-14 2003-03-25 Pharmafoods Kenkyusho:Kk 排尿機能改善用食品組成物及びそれを含有する飲食品
KR20090118994A (ko) * 2002-12-13 2009-11-18 워너-램버트 캄파니 엘엘씨 하부요로증상을 치료하기 위한 알파-2-델타 리간드
CA2451267A1 (en) 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
EP1480631B1 (en) * 2002-12-20 2007-08-01 Dynogen Pharmaceuticals Inc. Methods of treating non-painful bladder disorders using alpha2-delta- subunit calcium channel modulators
EP1621193A3 (en) * 2002-12-20 2006-08-02 Dynogen Pharmaceuticals Inc. Treatment of non-painful bladder disorders using alpha2-delta-subunit calcium channel modulators
KR100742001B1 (ko) * 2003-03-21 2007-07-23 다이노젠 파마세우티컬스, 인코포레이티드 평활근 모듈레이터 및 알파2 델타 서브유닛 칼슘 채널모듈레이터를 이용한 하부 요로 질환의 치료 방법
NZ545884A (en) * 2003-09-11 2010-01-29 Xenoport Inc Treating and/or preventing urinary incontinence using prodrugs of GABA analogs
PL1677767T3 (pl) 2003-10-14 2011-12-30 Xenoport Inc Krystaliczna postać analogu kwasu gamma-aminomasłowego
UA94979C2 (uk) * 2006-12-22 2011-06-25 Рекордати Айеленд Лимитед КОМБІНОВАНА ТЕРАПІЯ ПОРУШЕНЬ НИЖНІХ СЕЧОВИВІДНИХ ШЛЯХІВ ЛІГАНДАМИ α2δ І НПЗП
EP2240158A2 (en) * 2007-12-28 2010-10-20 Intas Pharmaceuticals Limited Stabilized injectable formulation of pregabalin
WO2009094577A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
US7872046B2 (en) 2008-01-25 2011-01-18 Xenoport, Inc. Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
TWI380812B (zh) 2008-01-25 2013-01-01 Xenoport Inc （３ｓ）-胺甲基-５-甲基己酸前藥之晶形及使用方法
ES2423254B1 (es) * 2012-02-15 2014-03-26 Laboratec, S.L. Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9137091A (en) * 1990-11-27 1992-06-25 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
SK283281B6 (sk) * 1992-05-20 2003-05-02 Northwestern University Deriváty gamaaminomaslovej kyseliny, spôsoby a medziprodukty na ich výrobu, ich použitie a farmaceutické prostriedky
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
US20020045742A1 (en) * 1998-12-15 2002-04-18 Kenneth A. Jones Dna encoding a gaba b r2 polypeptide and uses thereof

Also Published As

Publication number Publication date
KR20010103053A (ko) 2001-11-17
DE60044160D1 (de) 2010-05-20
ES2341059T3 (es) 2010-06-14
AU2741600A (en) 2000-11-14
DE60040784D1 (de) 2008-12-24
EP1977745A1 (en) 2008-10-08
ATE413872T1 (de) 2008-11-15
CA2362026A1 (en) 2000-10-19
ATE463242T1 (de) 2010-04-15
JP2002541198A (ja) 2002-12-03
WO2000061135A1 (en) 2000-10-19
EP1171114B1 (en) 2008-11-12
AU2005200619A1 (en) 2005-03-10
IL145763A0 (en) 2002-07-25
EP1977745B1 (en) 2010-04-07
TR200102837T2 (tr) 2002-03-21
ES2313880T3 (es) 2009-03-16
HUP0200738A3 (en) 2003-03-28
AU779262B2 (en) 2005-01-13
EP1171114A1 (en) 2002-01-16
AU779262C (en) 2000-11-14
HUP0200738A2 (hu) 2002-07-29

Similar Documents

Publication Publication Date Title
WO2000002546A3 (en) Use of caba-analogues for treating insomnia
IL145763A0 (en) Method for the treatment of incontinence
IL126999A0 (en) Isobutylgaba and its derivatives for the treatment of pain
EP1039887A4 (en) PROCESS FOR THE TREATMENT OF NEURO AND NEPHROTOXICITIES AND THERAPEUTIC TOXICITIES WITH AMINOTHIOL COMPOUNDS
IL208903A0 (en) Nociceptin analogs
AU2001251546A1 (en) Method for treating pain by peripheral administration of a neurotoxin
WO2001078711A3 (en) Pde-v inhibitors for treatment of parkinson's disease
HK1043306A1 (en) 16-phenoxy-lipoxin analogs for medical use
EP1712236A3 (en) Tetracyclines for the treatment of acne
IL162384A0 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
WO2002096362A3 (en) Method for treating fibrotic diseases or other indications vi
IL145122A0 (en) C16 unsaturated fp-selective prostaglandin analogs
BG105953A (en) Method for treating copd
UA66792C2 (uk) Спосіб отримання 2-арил-3-арил-5-галогенпіридинів, що використовуються як інгібітори сох-2 (варіанти)
IT1271141B (it) Procedimento per la potabilizzazione delle acque destinate al consumo umano
ZA976854B (en) Treatment of psychotic disorders.
HUT70757A (en) Pharmaceutical compositions for treating skin disorders
MY133014A (en) Method for treating copd
HK1061355A1 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
WO2002067851A3 (en) Method for treating fibrotic diseases or other indications iiic
PL345953A1 (en) The treatment of renal colic with gaba analogs
SI1304107T1 (en) Use of oxazolidinines derivatives for treating psoriasis